Page 2 - Managed Access Program News Today

SAN FRANCISCO, Jan. 11, 2023 /PRNewswire/ -- The global spinal muscular atrophy treatment market size is expected to reach USD 18.0 billion by 2030, according to a new study by Grand View

Dublin, Dec. 23, 2022 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy Treatment Market Size, Share & Trends Analysis Report By Type (Type1, Type 2),...

/PRNewswire/ -- Spinal Muscular Atrophy Treatment Market Size, Share & Trends Analysis Report By Type (Type1, Type 2), By Treatment (Gene Therapy, Drug), By...

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., June 22, 2022 /PRNewswire/ -- Neuroinflammatory disorder is the study of conditions where immune responses which damage components

/PRNewswire/ -- Neuroinflammatory disorder is the study of conditions where immune responses which damage components of the nervous system. It includes many...

"We didn't know what this was, but when we Googled it, our world came crashing down".

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' announced today that lenzilumab is now

(RTTNews) - Humanigen, Inc. (HGEN), Thursday said its antibody, Lenzilumab is now available for certain hospitalized Covid-19 patients through its...

A 9-year-old patient with recurrent fever, urticarial rash and demyelinating brain lesions: nlrp3- autoinflammatory disease in Ecuador

Molten Ventures 909.5p  £1392m (LON:GROW) The venture capital firm investing in and developing high growth digital technology businesses,...